Scott L Carter

10PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 18, 2024
ROBUST DISCOVERY OF MUTATIONAL SIGNATURES USING POWER POSTERIORS.

Catherine Xue, Jeffrey W Miller, Scott L Carter

|Jan 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.

Sarah Jenkins, Wei Zhang, Seth M Steinberg

|Jun 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.

Christopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking

|Oct 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.

Priscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee

|Oct 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.

Sanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson

|Feb 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.

Alyssa L Kennedy, Kasiani C Myers, James Bowman

Pageof 2